Tower Wealth Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$577K Buy
2,612
+598
+30% +$165K 0.28% 42
2026
Q1
$595K Buy
2,014
+99
+5% +$29.4K 0.33% 34
2025
Q4
$523K Buy
1,915
+87
+5% +$23.6K 0.29% 41
2025
Q3
$494K Buy
1,828
+153
+9% +$41.6K 0.27% 42
2025
Q2
$462K Buy
1,675
+19
+1% +$5.17K 0.27% 39
2025
Q1
$439K Sell
1,656
-203
-11% -$50.1K 0.23% 44
2024
Q4
$432K Buy
1,859
+752
+68% +$173K 0.23% 41
2024
Q3
$244K Sell
1,107
-19
-2% -$3.93K 0.14% 59
2024
Q2
$221K Sell
1,126
-434
-28% -$89.7K 0.14% 62
2024
Q1
$336K Sell
1,560
-78
-5% -$16.4K 0.22% 46
2023
Q4
$345K Buy
+1,638
New +$350K 0.24% 41

Other funds holding CME

Tower Wealth Partners's CME Position: Q2 2026 in Review

Tower Wealth Partners increased its CME Group (CME) stake by 30% in Q2 2026, buying an estimated $165K and bringing the position to 2,612 shares worth $577K. The position accounts for 0.28% of the portfolio, ranked #42.

Tower Wealth Partners first reported a position in CME in Q4 2023 and has held it in 11 quarters since. The position peaked at $595K in Q1 2026. 1,704 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Tower Wealth Partners held 2,612 shares of CME Group worth $577K as of Q2 2026.
  • Tower Wealth Partners bought 598 CME Group shares in Q2 2026, an estimated $165K.
  • CME Group made up 0.28% of Tower Wealth Partners's portfolio in Q2 2026, its #42 holding.
  • Tower Wealth Partners first reported a position in CME Group in Q4 2023 and has held it in 11 quarters since.
  • Tower Wealth Partners's CME Group position peaked at $595K in Q1 2026.
  • 1,704 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Tower Wealth Partners's 13F filing for Q2 2026, filed 12 Aug 2026.